Partnership
PsiQuantum x DARPA (Utility-Scale Quantum Computing)
DARPA selected PsiQuantum (alongside Microsoft) for the final phase of its Utility-Scale Quantum Computing program, with a 25 million expanded agreement to evaluate and build a utility-scale quantum computer.
development · Active · operating
Machine-readable surfaces
- Markdown mirror: /partnerships/psiquantum-x-darpa-utility-scale-quantum-computing.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/partnerships/psiquantum-x-darpa-utility-scale-quantum-computing
- Revision history: /partnerships/psiquantum-x-darpa-utility-scale-quantum-computing/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
ea4a5fe5-461e-47e8-8888-5710dc88aef9- Type
- development
- Status
- Activeoperating
- Announced
- 2025-02-261.5 years ago
- Active for
- 1.5 years
Who’s involved
PsiQuantum is building the world's first utility-scale, fault-tolerant quantum computers using photonic qubits and silicon photonics. Founded in 2016, the company has raised nearly USD 2 billion in private capital and is constructing datacenter-sized Quantum Compute Centers in Brisbane, Australia and Chicago, Illinois, with utility-scale systems targeted for 2027. PsiQuantum collaborates with NVIDIA on GPU-QPU integration and has a USD 125 million agreement with DARPA under the Utility-Scale Quantum Computing program.
Off-registry parties
- DARPA · customer
Related partnerships
Recent partnerships of the same kind
- Threod Systems x First ShieldFirst Shield + Threod Systemsdevelopment—operating
- Entegris x SEMATECHEntegris + SEMATECHdevelopment—operating
- RIKEN BDR x Otsuka Pharmaceutical CollaborationRIKEN Center for Biosystems Dynamics + Otsuka Pharmaceuticaldevelopment—operating
- Kautex Textron RESiLiTE Horizon EuropeKautex Textron + Horizon Europe EU Programmedevelopment—operating
- Canvas x USG CorporationCanvas + USG Corporationdevelopment—operating
- development—operating
Sources (1)
Deploy Watch
Track this partnership.
We notify you when the status changes against primary-source evidence, expansion is verified, or the partnership is terminated.